HLA heterozygosity contributes to susceptibility to rheumatoid arthritis.

We have investigated the role of HLA-DR genotypes in 184 patients with severe rheumatoid arthritis (RA) and in 46 patients with Felty syndrome, to establish the relative contribution of the RA-associated subtypes of DR4 (Dw4, Dw14, and Dw15). There was an excess of DR4 homozygotes, particularly Dw4/Dw14 compound heterozygotes (relative risk [RR] 49). The risk associated with Dw4 depended on the other allele present--Dw4/DR1 (RR 21), Dw4/Dw4 (RR 15), and Dw4/DRX (RR 6). There was a significant risk from Dw4/Dw14 compared with Dw4/Dw4, both in those with severe RA (RR 2.9; P less than .02) and in those with Felty syndrome (RR 4.2; P less than .02). In contrast, in a further 63 known DR4 homozygotes with RA, not selected for severe disease, the excess of Dw4/Dw14 was much less striking (RR 1.4; not significant), suggesting that this genotype may be particularly associated with more severe disease. We also found four cases with the rare Dw4/Dw15 genotype (expected less than or equal to 0.5; P less than or equal to .02). Since the Dw4, Dw14, Dw15, and DR1 molecules have similar antigen-binding sites and since combinations of these alleles particularly predispose to severe RA, we suggest that synergistic mechanisms are involved. These could include an effect on T-cell repertoire selection.

[1]  G. Lathrop.  Estimating genotype relative risks. , 2008, Tissue antigens.

[2]  J. Monaco,et al.  Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes , 1991, Nature.

[3]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[4]  Paul Wordsworth,et al.  Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. , 1991, Human immunology.

[5]  Bryan Paul Wordsworth.  HLA class II antigens in susceptibility to rheumatoid arthritis. , 1991, British journal of rheumatology.

[6]  T. Pincus,et al.  HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis. , 1990, Arthritis and rheumatism.

[7]  I. James,et al.  The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. , 1990, Medicine.

[8]  K. Welsh,et al.  Sequence analysis of HLA-DR4B1 subtypes: additional first domain variability is detected by oligonucleotide hybridization and nucleotide sequencing. , 1990, Human immunology.

[9]  J. Bell,et al.  HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. R. Rowe,et al.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. , 1989, The Journal of clinical investigation.

[11]  M. Baur,et al.  Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. , 1988, American journal of human genetics.

[12]  F. Wolfe,et al.  HLA-DR4 genotype frequency and gender effect in familial rheumatoid arthritis. , 1988, Tissue antigens.

[13]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[14]  A. Silman,et al.  HLA and rheumatoid arthritis: a combined analysis of 440 British patients. , 1986, Annals of the rheumatic diseases.

[15]  A. Silman,et al.  HLA and rheumatoid arthritis: an analysis of multicase families. , 1986, Disease markers.

[16]  A. Silman,et al.  A multicase family study of rheumatoid arthritis in south west Ireland. , 1986, Disease Markers.

[17]  J. Nicklas,et al.  Southern analysis of DNA polymorphism among Dw subtypes of DR4. , 1985, Human immunology.

[18]  J. Hansen,et al.  Specific HLA-DR4-associated histocompatibility molecules characterize patients with seropositive juvenile rheumatoid arthritis. , 1984, The Journal of clinical investigation.

[19]  H. Mitsui,et al.  HLA DR4 and rheumatoid arthritis in Japanese people. , 1981, Annals of the rheumatic diseases.

[20]  G. A. Bennett,et al.  1958 Revision of diagnostic criteria for rheumatoid arthritis. , 1959, Bulletin on the rheumatic diseases.

[21]  G. Nepom,et al.  Association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the "shared epitope" hypothesis. , 1991, Arthritis and rheumatism.

[22]  A. Silman,et al.  Investigating the HLA component in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred , 1991, Genetic epidemiology.

[23]  M. Davis,et al.  T cell receptor gene diversity and selection. , 1990, Annual review of biochemistry.

[24]  J. H. Brown.  A hypothetical model of the foreign antigen binding site of Class II histocompatibility molecules , 1988, Nature.

[25]  P. Gregersen,et al.  Molecular diversity of HLA-DR4 haplotypes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.